WHO Approves Chinese-Made COVID Vaccine for Emergency Use
Vaccine developed by Sinovac is effective in over half of those who were vaccinated
Vaccine developed by Sinovac is effective in over half of those who were vaccinated
Britain approves Johnson & Johnson's vaccine, its fourth vaccine approval
Bloc once counted on British-Swedish company as a linchpin in its Covid-19 vaccination campaignit's since turned to other options
WHO: Variant circulating in India is of 'global' concern
Vaccine was developed by Chinese drugmaker Sinopharm
Sinopharm first non-Western vaccine approved by WHO
Action taken to compensate for disruptions rollout caused by issues with other vaccines
The vaccine is currently authorized for emergency use in the United States for people age 16 and older
Federal health officials restrict recipients to 60 years old and older after 31 cases of blood clots were reported, including nine deaths
Britain, main supplier of AstraZeneca vaccine, has been focus of new export rules
US is sending vaccines to neighbors Canada, Mexico
A number of European nations have suspended use of the vaccine due to safety concerns
Populist parties bash the EU's vaccine rollout, but are quieter about leaving the bloc
Move comes just as the nation is about to surpass 100K COVID-19 deaths
Commission president says 'Green Pass' will be presented later this month
One-dose shot will be available for inoculations as early as Tuesday morning
One-dose shot is third, behind Pfizer-BioNTech and Moderna, to win FDA approval
Food and Drug Administration says drugmakers do not have to conduct large-scale clinical trials for vaccines adapted to fight new coronavirus variants
South Africa carries the bulk of the continent's cases, with 1.49 million confirmed infections and 48,000 deaths
Vaccine developed jointly with Oxford University has been limited due to lack of data on efficacy among elderly ////
Johannesburg said it would pause its AstraZenaca inoculation program because of the vaccine's limited effectiveness against the COVID variant dominant
Agency chief says 75% of all vaccinations are in just 10 countries
Drugmaker's application for its single-dose vaccine to US Food and Drug Administration follows January report that found the vaccine had a 66% rate of
Mexico regulatory agency grants emergency authorization of/Russian Sputnik V vaccine as it prepares to launch vaccination program ///
European Medicines Agency calls vaccine effective, despite concerns about older people